Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $31,428 | 22 | 79.7% |
| Food and Beverage | $5,313 | 161 | 13.5% |
| Travel and Lodging | $2,671 | 16 | 6.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Flexion Therapeutics, Inc. | $24,414 | 40 | $0 (2020) |
| Pacira Therapeutics, Inc. | $8,039 | 7 | $0 (2021) |
| Arthrex, Inc. | $3,169 | 31 | $0 (2024) |
| Horizon Therapeutics plc | $821.29 | 28 | $0 (2022) |
| Horizon Pharma plc | $795.66 | 23 | $0 (2018) |
| DePuy Synthes Sales Inc. | $648.37 | 33 | $0 (2024) |
| Anika Therapeutics, Inc. | $433.40 | 4 | $0 (2019) |
| Suvon Surgical Llc | $392.12 | 4 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $303.48 | 15 | $0 (2023) |
| Pacira Pharmaceuticals Incorporated | $168.22 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,900 | 22 | Arthrex, Inc. ($1,480) |
| 2023 | $273.69 | 3 | Arthrex, Inc. ($253.24) |
| 2022 | $16.68 | 1 | Horizon Therapeutics plc ($16.68) |
| 2021 | $8,224 | 12 | Pacira Therapeutics, Inc. ($8,039) |
| 2020 | $10,518 | 38 | Flexion Therapeutics, Inc. ($9,158) |
| 2019 | $16,675 | 73 | Flexion Therapeutics, Inc. ($15,089) |
| 2018 | $764.34 | 24 | Horizon Pharma plc ($404.31) |
| 2017 | $1,040 | 26 | Anika Therapeutics, Inc. ($417.59) |
All Payment Transactions
199 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/21/2024 | DePuy Synthes Sales Inc. | ORTHOVISC (Device) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Sports Early Intervention | ||||||
| 03/11/2024 | Suvon Surgical Llc | — | Food and Beverage | In-kind items and services | $68.94 | General |
| 02/29/2024 | Bioventus LLC | DUROLANE (Device) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: ORTHOPEDICSORTHOPEDIC SURGERY | ||||||
| 01/23/2024 | Suvon Surgical Llc | — | Food and Beverage | In-kind items and services | $120.99 | General |
| 01/23/2024 | Suvon Surgical Llc | — | Food and Beverage | In-kind items and services | $111.77 | General |
| 01/23/2024 | Suvon Surgical Llc | — | Food and Beverage | In-kind items and services | $90.42 | General |
| 01/21/2024 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $24.00 | General |
| 01/21/2024 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $15.00 | General |
| 01/20/2024 | Arthrex, Inc. | — | Travel and Lodging | In-kind items and services | $427.35 | General |
| 01/20/2024 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $45.00 | General |
| 01/20/2024 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $45.00 | General |
| 01/20/2024 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $10.00 | General |
| 01/20/2024 | Arthrex, Inc. | — | Travel and Lodging | In-kind items and services | $5.09 | General |
| 01/20/2024 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $5.00 | General |
| 01/20/2024 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $5.00 | General |
| 01/20/2024 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $5.00 | General |
| 01/20/2024 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $5.00 | General |
| 01/20/2024 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $5.00 | General |
| 01/20/2024 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $5.00 | General |
| 01/19/2024 | Arthrex, Inc. | — | Travel and Lodging | In-kind items and services | $427.35 | General |
| 01/19/2024 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $24.00 | General |
| 01/18/2024 | Arthrex, Inc. | — | Travel and Lodging | In-kind items and services | $427.35 | General |
| 12/18/2023 | DePuy Synthes Sales Inc. | ORTHOVISC (Device) | Food and Beverage | In-kind items and services | $5.93 | General |
| Category: Sports Early Intervention | ||||||
| 12/12/2023 | Ferring Pharmaceuticals Inc. | EUFLEXXA (Device) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: ORTHOPEDICS | ||||||
| 12/04/2023 | Arthrex, Inc. | — | Travel and Lodging | In-kind items and services | $253.24 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,126 | 5,221 | $1.1M | $254,656 |
| 2022 | 9 | 960 | 6,614 | $1.2M | $272,904 |
| 2021 | 11 | 1,048 | 7,407 | $1.2M | $282,903 |
| 2020 | 15 | 1,177 | 4,917 | $1.0M | $218,420 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J7324 | Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | Office | 2023 | 197 | 944 | $530,528 | $94,595 | 17.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 302 | 858 | $205,920 | $62,514 | 30.4% |
| J3304 | Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | Office | 2023 | 27 | 2,592 | $160,704 | $34,571 | 21.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 204 | 334 | $92,518 | $24,103 | 26.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 117 | 162 | $66,582 | $17,658 | 26.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 115 | 115 | $73,025 | $16,181 | 22.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 43 | 43 | $18,146 | $3,921 | 21.6% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 94 | 144 | $1,872 | $852.81 | 45.6% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 27 | 29 | $696.00 | $261.58 | 37.6% |
| J7324 | Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | Office | 2022 | 181 | 890 | $500,180 | $100,087 | 20.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 275 | 790 | $189,600 | $61,353 | 32.4% |
| J3304 | Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | Office | 2022 | 44 | 4,288 | $265,856 | $58,361 | 22.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 186 | 307 | $85,039 | $24,036 | 28.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 104 | 142 | $58,362 | $15,854 | 27.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 74 | 74 | $46,990 | $10,583 | 22.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 25 | 25 | $10,550 | $2,073 | 19.7% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 51 | 76 | $988.00 | $379.94 | 38.5% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2022 | 20 | 22 | $528.00 | $175.62 | 33.3% |
| J7324 | Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | Office | 2021 | 177 | 868 | $487,816 | $93,878 | 19.2% |
| J3304 | Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | Office | 2021 | 66 | 4,833 | $299,646 | $70,049 | 23.4% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 282 | 964 | $231,360 | $63,020 | 27.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 211 | 336 | $93,072 | $27,285 | 29.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 81 | 97 | $39,867 | $11,338 | 28.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 66 | 66 | $41,910 | $9,556 | 22.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 62 | 62 | $26,164 | $6,075 | 23.2% |
About Dr. Justin Classie, M.D
Dr. Justin Classie, M.D is a Sports Medicine healthcare provider based in Fresh Meadows, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/21/2009. The National Provider Identifier (NPI) number assigned to this provider is 1588896708.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Justin Classie, M.D has received a total of $39,411 in payments from pharmaceutical and medical device companies, with $1,900 received in 2024. These payments were reported across 199 transactions from 14 companies. The most common payment nature is "Honoraria" ($31,428).
As a Medicare-enrolled provider, Classie has provided services to 4,311 Medicare beneficiaries, totaling 24,159 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Sports Medicine
- Other Specialties Sports Medicine
- Location Fresh Meadows, NY
- Active Since 08/21/2009
- Last Updated 11/16/2022
- Taxonomy Code 207QS0010X
- Entity Type Individual
- NPI Number 1588896708
Products in Payments
- Zilretta (Drug) $32,453
- ORTHOVISC (Device) $635.98
- NO_PRODUCT (Drug) $562.08
- PENNSAID (Drug) $474.78
- HYALOFAST (Device) $433.40
- EUFLEXXA (Device) $303.48
- Exparel (Drug) $140.00
- Hymovis (Device) $117.20
- DUEXIS (Drug) $53.52
- Physio-Stim Osteogenesis Stimulator (Device) $45.42
- HYMOVIS (Device) $40.22
- EXPAREL (Drug) $28.22
- DUROLANE (Device) $13.92
- VIMOVO (Drug) $13.87
- MONOVISC (Device) $12.39
- Makoplasty (Device) $10.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.